• All sections
  • A - Human necessities
  • A61K - Preparations for medical, dental or toiletry purposes
  • A61K 47/60 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol

Patent holdings for IPC class A61K 47/60

Total number of patents in this class: 3945

10-year publication summary

225
351
433
391
435
421
404
384
326
9
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Nektar Therapeutics
432
89
Hanmi Pharm. Co., Ltd.
586
73
The Regents of the University of California
20324
61
Bristol-myers Squibb Company
4793
47
Ascendis Pharma A/S
190
46
The Johns Hopkins University
5762
42
Massachusetts Institute of Technology
10168
40
Ascendis Pharma Growth Disorders A/S
58
40
Synthorx, Inc.
80
35
Board of Regents, The University of Texas System
5966
34
Ascendis Pharma Bone Diseases A/S
48
27
Amgen Inc.
4275
26
Quiapeg Pharmaceuticals AB
44
26
Janssen Pharmaceutica N.V.
3345
24
NOK Corporation
2244
23
The Board of Trustees of the Leland Stanford Junior University
6553
22
Northwestern University
3468
22
Targimmune Therapeutics AG
40
21
SeaGen Inc
579
21
Duke University
3147
20
Other owners 3206